Pfizer Inc has petitioned the FDA to recall azithromycin products sold by Teva Pharmaceuticals U.S.A. and Sandoz Inc. that are generic versions of Pfizer’s antibiotic, Zithromax(R), claiming mislabeling of the packaging. The US patent for Zithromax expired in November 2005.
Pfizer has also brought patent infringement actions against both companies, claiming infringement of a patent covering azithromycin sesquihydrate, alleging that the drugs contain significant amounts of azithromycin sesquihydrate rather than the azithromycin monohydrate as claimed in the labeling.
Pfizer claims misbranding of Teva and Sandoz Generic Azithromycin Products
February 12, 2006
1 Comment | 
Israel Related, News, Teva, US Patent Office, pharmaceuticals and Biotechnology | 
Permalink
Posted by Dr Michael Factor
